ENVB

Conviction 12HealthcareScan · Thu, Jun 25, 2026

ENVB$1.27-3.05%

ResistanceSupportVol 14

Vol MA14 268.45K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Enveric Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.enveric.com ↗

Price1.27

Change-3.05%

Gap+0.00%

Rel volume0.31×

Avg volume217.64K

Avg $ vol347.21K

SMA 201.68

SMA 502.54

SMA 2002.97

Price vs 50-49.90%

Price vs 200-57.22%

MA stackbearish

50/200 cross—

Supertrenddown · 1.83

RSI (14)27

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D1 / 6

ADX (14)17

+DI / −DI19 / 28

RSI divergence—

MACD divergenceBullish

ATR %+17.10%

ADR %9.91%

52w high10.33

52w low0.5820

From 52w high-87.71%

Above 52w low+118.21%

New 52w highNo

SqueezeOff

Bollinger width85.93%

%B0.21

Donchian pos0.87%

Donchian high2.41

Donchian low1.26

AVWAP (52w high)4.91

vs AVWAP high-74.12%

AVWAP (52w low)4.70

vs AVWAP low-72.96%

OBV trendDown

Chaikin MF (20)-0.56

Today vs 20d0.31×

Avg vol (14d)268.45K

Avg vol (20d)217.64K

Avg $ vol (20d)347.21K

Market cap4.68M

RS 3m (vs SPY)-45.08%

RS 6m (vs SPY)-81.95%

RS line new highNo

Trend template3/8

Technical rank3.2

1 week-2.31%

1 month-43.05%

3 months-35.53%

6 months-75.76%

1 year+1.60%

YTD-65.40%

P/E-0.53

P/B0.92

P/S—

P/FCF-0.57

EPS-36.24

Div yield—

ROE-173.33%

ROA-158.87%

Debt/Eq0.00

Current11.67

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth8.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.84M

Revenue8.48M

Net income-1.63M

Gross profit1.89M

Free cash flow-8.15M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out3.68M

Employees6

ListedThu, Aug 24, 1995

Free float1.24M

Float %89.5%

Short interest26.58K

Days to cover0.1d

Short volume47.6%

Squeeze score10 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank3.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.40

Support1.26

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ENVB

All disclosures →

No recent disclosed trades by Congress in ENVB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ENVB · 8 buys

Insider	Side	Shares	Value	Traded	Filed
DeWitt Sheila Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
Coveney Kevin Michael Chief Financial Officer · Common Stock · 2026-06-01	Grant	133.33K	$0	2026-06-01	2026-06-03
Facchini Peter J. Chief Innovation Officer · Common Stock · 2026-06-01	Grant	25K	$0	2026-06-01	2026-06-03
WEBB MICHAEL D Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
Tucker Joseph Edward Chief Executive Officer · Common Stock · 2026-06-01	Grant	201.12K	$0	2026-06-01	2026-06-03
Schabacker Marcus Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
Kegler George A. Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
PASQUALONE FRANK Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03

SEC filings

EDGAR filings in ENVB · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.